Loading company…
Vancouver-based company developing repurposed drugs for chronic diseases such as NASH, chronic kidney disease and IBD.
NASH Pharmaceuticals Inc. is headquartered in Vancouver, Canada, and develops new therapeutic uses for existing drugs. Its focus includes non-alcoholic steatohepatitis, chronic kidney disease and inflammatory bowel disease, and the company reports seven drug candidates advanced into phase II clinical trials. Revenue is expected from partnerships and licensing agreements with pharmaceutical companies. In June 2017 it raised an undisclosed amount from Bullrun Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in